These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17851192)

  • 21. Human analogue of the morris water maze for testing subjects at risk of Alzheimer's disease.
    Laczó J; Andel R; Vyhnalek M; Vlcek K; Magerova H; Varjassyova A; Tolar M; Hort J
    Neurodegener Dis; 2010; 7(1-3):148-52. PubMed ID: 20197695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort.
    Dufouil C; Dubois B; Vellas B; Pasquier F; Blanc F; Hugon J; Hanon O; Dartigues JF; Harston S; Gabelle A; Ceccaldi M; Beauchet O; Krolak-Salmon P; David R; Rouaud O; Godefroy O; Belin C; Rouch I; Auguste N; Wallon D; Benetos A; Pariente J; Paccalin M; Moreaud O; Hommet C; Sellal F; Boutoleau-Bretonniére C; Jalenques I; Gentric A; Vandel P; Azouani C; Fillon L; Fischer C; Savarieau H; Operto G; Bertin H; Chupin M; Bouteloup V; Habert MO; Mangin JF; Chêne G;
    Alzheimers Res Ther; 2017 Aug; 9(1):67. PubMed ID: 28851447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of mild cognitive impairment tending to convert into Alzheimer's disease or dementia with Lewy bodies: A follow-up study in a memory clinic.
    Kondo D; Ota K; Kasanuki K; Fujishiro H; Chiba Y; Murayama N; Sato K; Hirayasu Y; Arai H; Iseki E
    J Neurol Sci; 2016 Oct; 369():102-108. PubMed ID: 27653873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid tau protein and periventricular white matter lesions in patients with mild cognitive impairment: implications for 2 major pathways.
    Maruyama M; Matsui T; Tanji H; Nemoto M; Tomita N; Ootsuki M; Arai H; Sasaki H
    Arch Neurol; 2004 May; 61(5):716-20. PubMed ID: 15148149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies.
    Mitchell AJ; Shiri-Feshki M
    Acta Psychiatr Scand; 2009 Apr; 119(4):252-65. PubMed ID: 19236314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
    Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
    J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
    Meyer JS; Huang J; Chowdhury MH
    J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic transitions in mild cognitive impairment subtypes.
    Forlenza OV; Diniz BS; Nunes PV; Memória CM; Yassuda MS; Gattaz WF
    Int Psychogeriatr; 2009 Dec; 21(6):1088-95. PubMed ID: 19691909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High rate of conversion to Alzheimer's disease in a cohort of amnestic MCI patients.
    Schmidtke K; Hermeneit S
    Int Psychogeriatr; 2008 Feb; 20(1):96-108. PubMed ID: 17506911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
    Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
    Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential and subtype-specific neuroimaging abnormalities in amnestic and nonamnestic mild cognitive impairment: A systematic review and meta-analysis.
    Yeung MK; Chau AK; Chiu JY; Shek JT; Leung JP; Wong TC
    Ageing Res Rev; 2022 Sep; 80():101675. PubMed ID: 35724862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of neuropsychiatric symptoms in mild cognitive impairment.
    Monastero R; Mangialasche F; Camarda C; Ercolani S; Camarda R
    J Alzheimers Dis; 2009; 18(1):11-30. PubMed ID: 19542627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging.
    Meyer J; Xu G; Thornby J; Chowdhury M; Quach M
    J Neurol Sci; 2002 Sep; 201(1-2):19-25. PubMed ID: 12163189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive disturbances in non-demented subjects: heterogeneity of neuropsychological pictures.
    Sinforiani E; Zucchella C; Pasotti C
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():375-80. PubMed ID: 17317478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of cognitive deficits and conversion to dementia in patients with mild cognitive impairment: a very-long-term follow-up study.
    Hodges JR; Erzinçlioğlu S; Patterson K
    Dement Geriatr Cogn Disord; 2006; 21(5-6):380-91. PubMed ID: 16601329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment: prognosis and conversion to dementia.
    Rountree SD; Waring SC; Chan WC; Lupo PJ; Darby EJ; Doody RS
    Dement Geriatr Cogn Disord; 2007; 24(6):476-82. PubMed ID: 17992015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment.
    Jessen F; Wiese B; Bachmann C; Eifflaender-Gorfer S; Haller F; Kölsch H; Luck T; Mösch E; van den Bussche H; Wagner M; Wollny A; Zimmermann T; Pentzek M; Riedel-Heller SG; Romberg HP; Weyerer S; Kaduszkiewicz H; Maier W; Bickel H;
    Arch Gen Psychiatry; 2010 Apr; 67(4):414-22. PubMed ID: 20368517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia.
    Fischer P; Jungwirth S; Zehetmayer S; Weissgram S; Hoenigschnabl S; Gelpi E; Krampla W; Tragl KH
    Neurology; 2007 Jan; 68(4):288-91. PubMed ID: 17242334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting rapid clinical progression in amnestic mild cognitive impairment.
    Ahmed S; Mitchell J; Arnold R; Nestor PJ; Hodges JR
    Dement Geriatr Cogn Disord; 2008; 25(2):170-7. PubMed ID: 18212499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mild cognitive impairment: directions for future research.
    Luis CA; Loewenstein DA; Acevedo A; Barker WW; Duara R
    Neurology; 2003 Aug; 61(4):438-44. PubMed ID: 12939414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.